Immunocore Holdings Plc Revenue per Employee (IMCR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Immunocore Holdings Plc  (NASDAQ: IMCR)
 

Immunocore Holdings Plc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 18.34% in the second quarter 2026, year on year to cumulative value of $431 million, Immunocore Holdings Plc's revenue per employee grew on a trailing twelve months basis to $ 822,090, this marks a new company high.
Within the Healthcare sector Employees of 105 other companies have achieved higher revenue per employee. While Immunocore Holdings Plc's total ranking has deteriorated compared to the previous quarter from 739 to 1093. Immunocore Holdings Plc has 524 employees.


What is Sales per Employee Ratio?







IMCR Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 18.34 % 13.63 % 24.3 % 29.22 % 29.93 %
Sales per Employee (TTM) $ 822,090 787,809 763,389 724,408 679,666
IMCR's Total Ranking # 1093 # 739 # 412 # 498 # 355
Seq. Revenue Change 8.67 % 2.1 % 0.76 % 5.85 % 4.35 %


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 106
Overall Market # 1093

Revenue per Employee Statistics
High Average Low
$ 822,090 $ 715,137 $ 591,989
(Jun 30 2026)   (Dec 31 2024)



Financial Statements
Immunocore Holdings Plc's Revenue MRQ $ 116 Millions Visit IMCR's Income Statement
Immunocore Holdings Plc's Revenues TTM $ 431 Millions Visit IMCR's aggregate revenue growth
What are IMCR's Sales? Visit IMCR's Sales by Segment




Other Ratios
Immunocore Holdings Plc's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
IMCR's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for IMCR's Competitors
Revenue per Employee for IMCR's Suppliers
Revenue per Employee for IMCR's Customers

You may also want to know
IMCR's Sales Growth Rates IMCR's Pe Price to earnings ratio IMCR's Receivables Turnover Ratio IMCR's Stock Quote
IMCR's Net Income Growth Rates IMCR's Ps Price to Sales ratio IMCR's Sales per Employee IMCR's Asset Turnover Ratio
IMCR's Net Margin IMCR's Pb Price to Book ratio IMCR's Financial Strength Ratios IMCR's Dividend Payout Ratio
Date modified: 2026-09-05T15:13:44+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Acadia Pharmaceuticals Inc   1,426,870.93 $ 1,138.643  Million 798 
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Akebia Therapeutics Inc   1,129,175.26 $ 219.060  Million 194 
Siga Technologies Inc  1,095,079.92 $ 53.659  Million 49 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Evolus Inc   949,440.12 $ 317.113  Million 334 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
Ardelyx inc   922,073.62 $ 450.894  Million 489 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 
Pacira Biosciences inc   900,077.20 $ 746.164  Million 829 
Fortress Biotech Inc   897,217.95 $ 69.983  Million 78 
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.